Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,026 public trials 1,170 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Recruiting

A Phase 1 Study of the Safety and Tolerability of CTX-10726

NCT07419841

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +28 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Nebraska Cancer Specialists Omaha, Nebraska, United States
  • START New York Lake Success, New York, United States
  • UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
View Trial Details
Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

NCT07293351

Conditions
Adenocarcinoma, Advanced Renal Cell Carcinoma (RCC), Carcinoma, +14 more
Locations
  • Local Institution - 0178 Palo Alto, California, United States
  • Local Institution - 0117 New Haven, Connecticut, United States
  • Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • Local Institution - 0177 Miami, Florida, United States
View all 91 locations
View Trial Details
Recruiting

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

NCT07080242

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +18 more
Locations
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • UCLA Los Angeles, California, United States
  • UCSF- San Francisco (Helen Diller Family Comprehensive Cancer Center) San Francisco, California, United States
View all 20 locations
View Trial Details
Recruiting

A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice

NCT07284121

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
Locations
  • Landesklinikum Krems Krems, Austria
  • Ordensklinikum Linz Elisabethinen Linz, Austria
  • Krankenhaus Nord - Klinik Floridsdorf Vienna, Austria
  • Klinikum Wels-Grieskirchen Wels, Austria
View all 91 locations
View Trial Details
Recruiting

Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS)

NCT04797299

Conditions
Adenocarcinoma, Breast Carcinoma In Situ, Carcinoma, +7 more
Locations
  • Arthur J.E. Child Comprehensive Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BC Cancer - Abbotsford Centre Abbotsford British Columbia, British Columbia, Canada
  • BC Cancer - Centre for the North (Prince George) Prince George, British Columbia, Canada
View all 25 locations
View Trial Details
Recruiting

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

NCT06047379

Conditions
Adenocarcinoma, Astrocytoma, Brain Diseases, +93 more
Locations
  • Precision NextGen Oncology Beverly Hills, California, United States
  • OPN Healthcare, Inc Glendale, California, United States
  • University of Southern California Los Angeles, California, United States
  • MDR Core Network Boynton Beach, Florida, United States
View Trial Details

Related conditions